🟢 Outlook Therapeutics is trading 5% up in after-hours trading

Outlook Therapeutics is trading at $0.51, up 5.31% in after-hours trading, with no confirmed company-specific catalyst identified.

• Latest company announcements found were a CFO discussion on October 6 and a chief commercial officer appointment, rather than news released on October 16.
• Recent coverage of Q3 results and launch outlook dates to August 14 and does not establish a fresh catalyst.
• Broader indexes fell on October 16; available evidence does not indicate the stock was moving with the market.